Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryptococcosis | 2 | 2022 | 25 | 1.580 |
Why?
|
| Invasive Pulmonary Aspergillosis | 2 | 2021 | 5 | 1.430 |
Why?
|
| Bacillus | 1 | 2022 | 15 | 0.790 |
Why?
|
| Noise | 1 | 2023 | 67 | 0.780 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2022 | 44 | 0.760 |
Why?
|
| Aspergillus fumigatus | 1 | 2020 | 23 | 0.700 |
Why?
|
| Bacteremia | 1 | 2022 | 192 | 0.660 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2019 | 11 | 0.650 |
Why?
|
| Scleritis | 1 | 2019 | 19 | 0.640 |
Why?
|
| Endophthalmitis | 1 | 2019 | 28 | 0.630 |
Why?
|
| Transfusion Reaction | 1 | 2019 | 41 | 0.630 |
Why?
|
| Intensive Care Units | 2 | 2021 | 734 | 0.630 |
Why?
|
| Cause of Death | 1 | 2021 | 392 | 0.630 |
Why?
|
| Endocarditis, Bacterial | 1 | 2019 | 42 | 0.620 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 181 | 0.560 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 143 | 0.550 |
Why?
|
| Hypertension, Malignant | 1 | 2016 | 2 | 0.530 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2016 | 12 | 0.530 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2016 | 15 | 0.530 |
Why?
|
| Ceftriaxone | 1 | 2016 | 19 | 0.520 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2016 | 10 | 0.520 |
Why?
|
| Chlamydia trachomatis | 1 | 2016 | 46 | 0.520 |
Why?
|
| Doxycycline | 1 | 2016 | 56 | 0.510 |
Why?
|
| Hepatitis | 1 | 2016 | 47 | 0.510 |
Why?
|
| Peritonitis | 1 | 2016 | 81 | 0.500 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 337 | 0.490 |
Why?
|
| Caregivers | 1 | 2023 | 810 | 0.490 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.490 |
Why?
|
| Chlamydia Infections | 1 | 2016 | 73 | 0.490 |
Why?
|
| Abdominal Pain | 1 | 2016 | 144 | 0.470 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 1689 | 0.430 |
Why?
|
| Onions | 1 | 2010 | 1 | 0.360 |
Why?
|
| Arthropod Antennae | 1 | 2010 | 1 | 0.360 |
Why?
|
| Genes, Insect | 1 | 2010 | 21 | 0.350 |
Why?
|
| Expressed Sequence Tags | 1 | 2010 | 41 | 0.350 |
Why?
|
| Diptera | 1 | 2010 | 28 | 0.340 |
Why?
|
| Insect Proteins | 1 | 2010 | 35 | 0.340 |
Why?
|
| Receptors, Odorant | 1 | 2010 | 39 | 0.340 |
Why?
|
| Medical Staff | 1 | 2023 | 16 | 0.210 |
Why?
|
| Humans | 13 | 2023 | 128020 | 0.200 |
Why?
|
| Nose Diseases | 1 | 2022 | 12 | 0.190 |
Why?
|
| Mucormycosis | 1 | 2022 | 21 | 0.190 |
Why?
|
| Blood Culture | 1 | 2022 | 20 | 0.190 |
Why?
|
| Gram-Negative Bacteria | 1 | 2022 | 68 | 0.190 |
Why?
|
| Orbital Diseases | 1 | 2022 | 28 | 0.190 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2023 | 201 | 0.180 |
Why?
|
| Propensity Score | 1 | 2022 | 264 | 0.170 |
Why?
|
| New York City | 1 | 2020 | 80 | 0.170 |
Why?
|
| Mobile Applications | 1 | 2023 | 159 | 0.170 |
Why?
|
| Perception | 1 | 2023 | 336 | 0.170 |
Why?
|
| Fatal Outcome | 1 | 2020 | 299 | 0.160 |
Why?
|
| Ceftazidime | 1 | 2019 | 6 | 0.160 |
Why?
|
| Streptococcus pyogenes | 1 | 2019 | 32 | 0.160 |
Why?
|
| Intravitreal Injections | 1 | 2019 | 55 | 0.160 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 7029 | 0.160 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2019 | 67 | 0.160 |
Why?
|
| Mitral Valve | 1 | 2019 | 85 | 0.150 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2019 | 57 | 0.150 |
Why?
|
| Vancomycin | 1 | 2019 | 78 | 0.150 |
Why?
|
| Vaccines | 1 | 2023 | 394 | 0.150 |
Why?
|
| Merozoite Surface Protein 1 | 1 | 2017 | 4 | 0.140 |
Why?
|
| Plasmodium yoelii | 1 | 2017 | 5 | 0.140 |
Why?
|
| Antigens, Protozoan | 1 | 2017 | 22 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2019 | 3371 | 0.140 |
Why?
|
| Adult | 4 | 2022 | 35177 | 0.140 |
Why?
|
| Protozoan Proteins | 1 | 2017 | 74 | 0.140 |
Why?
|
| Malaria | 1 | 2017 | 58 | 0.130 |
Why?
|
| Length of Stay | 1 | 2022 | 1114 | 0.130 |
Why?
|
| Contact Tracing | 1 | 2016 | 23 | 0.130 |
Why?
|
| Sex Work | 1 | 2016 | 20 | 0.130 |
Why?
|
| Echocardiography | 1 | 2019 | 623 | 0.130 |
Why?
|
| Directive Counseling | 1 | 2016 | 45 | 0.130 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 600 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 373 | 0.120 |
Why?
|
| Incidence | 1 | 2021 | 2614 | 0.110 |
Why?
|
| Retrospective Studies | 2 | 2022 | 14404 | 0.110 |
Why?
|
| Middle Aged | 3 | 2021 | 30813 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 994 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1012 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 4853 | 0.100 |
Why?
|
| Male | 4 | 2021 | 62758 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2016 | 481 | 0.100 |
Why?
|
| Renal Dialysis | 1 | 2016 | 420 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1473 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2022 | 5378 | 0.090 |
Why?
|
| Aged | 2 | 2021 | 21892 | 0.090 |
Why?
|
| Drosophila | 1 | 2010 | 142 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 940 | 0.070 |
Why?
|
| Female | 3 | 2021 | 68017 | 0.070 |
Why?
|
| Brain | 1 | 2019 | 2615 | 0.070 |
Why?
|
| Phylogeny | 1 | 2010 | 838 | 0.070 |
Why?
|
| Risk Factors | 1 | 2020 | 9696 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 2509 | 0.060 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 2820 | 0.060 |
Why?
|
| Japan | 1 | 2023 | 96 | 0.050 |
Why?
|
| Child | 1 | 2023 | 20636 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2016 | 10110 | 0.050 |
Why?
|
| Intention | 1 | 2023 | 162 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2508 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2022 | 572 | 0.040 |
Why?
|
| Immunity | 1 | 2017 | 132 | 0.030 |
Why?
|
| Virulence | 1 | 2017 | 252 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 98 | 0.030 |
Why?
|
| Pain | 1 | 2022 | 748 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2017 | 673 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2059 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 34487 | 0.020 |
Why?
|